Anastasios Stathis

机构：Ente Ospedaliero Cantonale, Institute of Oncology Research, Istituto Oncologico della Svizzera Italiana, Università della Svizzera italiana · ORCID：0000-0002-2859-7529

发表论文 569 篇 · 总被引 8401 次 · h-index 41

代表论文

• IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas (2026 · Blood · 被引 6)
• Pirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R follicular lymphoma: phase 1/2 BRUIN study (2025 · Blood Advances · 被引 5)
• Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial (2025 · Blood · 被引 4)
• TLD-1, a Novel Liposomal Doxorubicin, in Patients with Solid Tumors: Comparative Pharmacokinetics and Final Results of a Multicenter Phase 1 Study (SAKK 65/16) (2025 · Clinical Pharmacokinetics · 被引 1)
• SAKK 35/14 randomized trial of rituximab with or without ibrutinib for patients with untreated follicular lymphoma (2026 · British Journal of Haematology)
• Safety and preliminary efficacy results of a new micellar formulation of docetaxel in patients with metastatic castration-resistant prostate cancer - SAKK 67/20 trial (2026 · Cancer Chemotherapy and Pharmacology)